Editorial: Innovative OMICs-technology applications to reach a diagnosis and bring new therapies to immune-mediated neurological diseases

• Laura Otero-Ortega,
• Mireya Fernández-Fournier,
• Haritz Irizar,
• David Otaegui,
• Exuperio Díez-Tejedor

Affiliations

Laura Otero-Ortega

Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital, Universidad Autónoma de Madrid), Madrid, Spain

Mireya Fernández-Fournier

Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital, Universidad Autónoma de Madrid), Madrid, Spain

Haritz Irizar

Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, United States

David Otaegui

Multiple Sclerosis Group, Neurosciences Area, Biodonostia Health Research Institute, San Sebastian, Spain

Exuperio Díez-Tejedor

Neurological Sciences and Cerebrovascular Research Laboratory, Department of Neurology, Neuroscience Area of Hospital La Paz Institute for Health Research-IdiPAZ (La Paz University Hospital, Universidad Autónoma de Madrid), Madrid, Spain